These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 20807279

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Impaired Dynamic Sarcoplasmic Reticulum Ca Buffering in Autosomal Dominant CPVT2.
    Wleklinski MJ, Kryshtal DO, Kim K, Parikh SS, Blackwell DJ, Marty I, Iyer VR, Knollmann BC.
    Circ Res; 2022 Sep 30; 131(8):673-686. PubMed ID: 36102198
    [Abstract] [Full Text] [Related]

  • 23. Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations.
    Kujala K, Paavola J, Lahti A, Larsson K, Pekkanen-Mattila M, Viitasalo M, Lahtinen AM, Toivonen L, Kontula K, Swan H, Laine M, Silvennoinen O, Aalto-Setälä K.
    PLoS One; 2012 Sep 30; 7(9):e44660. PubMed ID: 22962621
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Alpha blockade potentiates CPVT therapy in calsequestrin-mutant mice.
    Kurtzwald-Josefson E, Hochhauser E, Bogachenko K, Harun-Khun S, Katz G, Aravot D, Seidman JG, Seidman CE, Eldar M, Shainberg A, Arad M.
    Heart Rhythm; 2014 Aug 30; 11(8):1471-9. PubMed ID: 24768611
    [Abstract] [Full Text] [Related]

  • 29. Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia.
    Fernández-Velasco M, Rueda A, Rizzi N, Benitah JP, Colombi B, Napolitano C, Priori SG, Richard S, Gómez AM.
    Circ Res; 2009 Jan 30; 104(2):201-9, 12p following 209. PubMed ID: 19096022
    [Abstract] [Full Text] [Related]

  • 30. Short communication: flecainide exerts an antiarrhythmic effect in a mouse model of catecholaminergic polymorphic ventricular tachycardia by increasing the threshold for triggered activity.
    Liu N, Denegri M, Ruan Y, Avelino-Cruz JE, Perissi A, Negri S, Napolitano C, Coetzee WA, Boyden PA, Priori SG.
    Circ Res; 2011 Jul 22; 109(3):291-5. PubMed ID: 21680895
    [Abstract] [Full Text] [Related]

  • 31. A mutation in calsequestrin, CASQ2D307H, impairs Sarcoplasmic Reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice.
    Dirksen WP, Lacombe VA, Chi M, Kalyanasundaram A, Viatchenko-Karpinski S, Terentyev D, Zhou Z, Vedamoorthyrao S, Li N, Chiamvimonvat N, Carnes CA, Franzini-Armstrong C, Györke S, Periasamy M.
    Cardiovasc Res; 2007 Jul 01; 75(1):69-78. PubMed ID: 17449018
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and potency of class I antiarrhythmic drugs for suppression of Ca2+ waves in permeabilized myocytes lacking calsequestrin.
    Galimberti ES, Knollmann BC.
    J Mol Cell Cardiol; 2011 Nov 01; 51(5):760-8. PubMed ID: 21798265
    [Abstract] [Full Text] [Related]

  • 33. Pathogenic mechanism of a catecholaminergic polymorphic ventricular tachycardia causing-mutation in cardiac calcium release channel RyR2.
    Xiong J, Liu X, Gong Y, Zhang P, Qiang S, Zhao Q, Guo R, Qian Y, Wang L, Zhu L, Wang R, Hao Z, Wen H, Zhang J, Tang K, Zang WF, Yuchi Z, Chen H, Chen SRW, Zheng W, Wang SQ, Xu YW, Liu Z.
    J Mol Cell Cardiol; 2018 Apr 01; 117():26-35. PubMed ID: 29477366
    [Abstract] [Full Text] [Related]

  • 34. Targeting intracellular calcium cycling in catecholaminergic polymorphic ventricular tachycardia: a theoretical investigation.
    Sung RJ, Lo CP, Hsiao PY, Tien HC.
    Am J Physiol Heart Circ Physiol; 2011 Oct 01; 301(4):H1625-38. PubMed ID: 21742998
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handling.
    Kirchhefer U, Wehrmeister D, Postma AV, Pohlentz G, Mormann M, Kucerova D, Müller FU, Schmitz W, Schulze-Bahr E, Wilde AA, Neumann J.
    J Mol Cell Cardiol; 2010 Jul 01; 49(1):95-105. PubMed ID: 20302875
    [Abstract] [Full Text] [Related]

  • 37. Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia.
    Faggioni M, Kryshtal DO, Knollmann BC.
    Pediatr Cardiol; 2012 Aug 01; 33(6):959-67. PubMed ID: 22421959
    [Abstract] [Full Text] [Related]

  • 38. Modulation of cytosolic and intra-sarcoplasmic reticulum calcium waves by calsequestrin in rat cardiac myocytes.
    Kubalova Z, Györke I, Terentyeva R, Viatchenko-Karpinski S, Terentyev D, Williams SC, Györke S.
    J Physiol; 2004 Dec 01; 561(Pt 2):515-24. PubMed ID: 15486014
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia.
    Gray B, Bagnall RD, Lam L, Ingles J, Turner C, Haan E, Davis A, Yang PC, Clancy CE, Sy RW, Semsarian C.
    Heart Rhythm; 2016 Aug 01; 13(8):1652-60. PubMed ID: 27157848
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.